Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation*

All eukaryotic forms of DNA topoisomerase I contain an extensive and highly charged N-terminal domain. This domain contains several nuclear localization sequences and is essential forin vivo function of the enzyme. However, so far no direct function of the N-terminal domain in the in vitrotopoisomerase I reaction has been reported. In this study we have compared the in vitro activities of a truncated form of human topoisomerase I lacking amino acids 1–206 (p67) with the full-length enzyme (p91). Using these enzyme forms, we have identified for the first time a direct role of residues within the N-terminal domain in modulating topoisomerase I catalysis, as revealed by significant differences between p67 and p91 in DNA binding, cleavage, strand rotation, and ligation. A comparison with previously published studies showing no effect of deleting the first 174 or 190 amino acids of topoisomerase I (Stewart, L., Ireton, G. C., and Champoux, J. J. (1999) J. Biol. Chem. 274, 32950–32960; Bronstein, I. B., Wynne-Jones, A., Sukhanova, A., Fleury, F., Ianoul, A., Holden, J. A., Alix, A. J., Dodson, G. G., Jardillier, J. C., Nabiev, I., and Wilkinson, A. J. (1999)Anticancer Res. 19, 317–327) suggests a pivotal role of amino acids 191–206 in catalysis. Taken together the presented data indicate that at least part(s) of the N-terminal domain regulate(s) enzyme/DNA dynamics during relaxation most probably by controlling non-covalent DNA binding downstream of the cleavage site either directly or by coordinating DNA contacts by other parts of the enzyme.

[1]  J. Champoux,et al.  Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. , 2000, Biochemistry.

[2]  S. Shuman,et al.  Catalytic mechanism of DNA topoisomerase IB. , 2000, Molecular cell.

[3]  T. Katayama,et al.  Mutant DnaA proteins defective in duplex opening of oriC, the origin of chromosomal DNA replication in Escherichia coli , 2000, Molecular microbiology.

[4]  J. Champoux,et al.  A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay* , 1999, The Journal of Biological Chemistry.

[5]  A. Wilkinson,et al.  Expression, purification and DNA-cleavage activity of recombinant 68-kDa human topoisomerase I-target for antitumor drugs. , 1999, Anticancer Research.

[6]  L. Liu,et al.  Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. , 1999, Nucleic acids research.

[7]  T. Straub,et al.  The RNA-splicing Factor PSF/p54 Controls DNA-Topoisomerase I Activity by a Direct Interaction* , 1998, The Journal of Biological Chemistry.

[8]  F. Boege,et al.  Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis. , 1998, Biochemistry.

[9]  P. Haluska,et al.  A role for the amino terminus of human topoisomerase I. , 1998, Advances in enzyme regulation.

[10]  J. Tazi,et al.  Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor. , 1998, Nucleic acids research.

[11]  Chonghui Cheng,et al.  Conservation of Structure and Mechanism between Eukaryotic Topoisomerase I and Site-Specific Recombinases , 1998, Cell.

[12]  W G Hol,et al.  A model for the mechanism of human topoisomerase I. , 1998, Science.

[13]  J. Champoux,et al.  Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.

[14]  M. Bjornsti,et al.  Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell Death* , 1997, The Journal of Biological Chemistry.

[15]  T. Straub,et al.  Separation and functional analysis of eukaryotic DNA topoisomerases by chromatography and electrophoresis. , 1996, Journal of chromatography. B, Biomedical applications.

[16]  L. Bracco,et al.  Modulation of DNA topoisomerase I activity by p53. , 1996, Biochemistry.

[17]  G. Ireton,et al.  The Domain Organization of Human Topoisomerase I (*) , 1996, The Journal of Biological Chemistry.

[18]  G. Ireton,et al.  Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I (*) , 1996, The Journal of Biological Chemistry.

[19]  J. Svejstrup,et al.  Purification and characterization of human topoisomerase I mutants. , 1996, European journal of biochemistry.

[20]  D. Kufe,et al.  Identification of a Nucleolin Binding Site in Human Topoisomerase I (*) , 1996, The Journal of Biological Chemistry.

[21]  R. Benbow,et al.  Casein kinase II stimulates Xenopus laevis DNA topoisomerase I by physical association. , 1994, Biochemistry.

[22]  Y. Shimizu,et al.  Phosphorylation of DNA topoisomerase I is increased during the response of mammalian cells to mitogenic stimuli. , 1994, Biochimica et biophysica acta.

[23]  A. Mildvan,et al.  Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. , 1994, Biochemistry.

[24]  O. Westergaard,et al.  Characterization of intra- and intermolecular DNA ligation mediated by eukaryotic topoisomerase I. Role of bipartite DNA interaction in the ligation process. , 1994, The Journal of biological chemistry.

[25]  G. Fink,et al.  A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest. , 1993, Genetics.

[26]  J. Alsner,et al.  Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. , 1992, The Journal of biological chemistry.

[27]  J. Svejstrup,et al.  New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. , 1991, Journal of molecular biology.

[28]  S. Shuman,et al.  Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. , 1990, The Journal of biological chemistry.

[29]  Y. Pommier,et al.  Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C. , 1990, The Journal of biological chemistry.

[30]  U. Mortensen,et al.  Interactions between eukaryotic DNA topoisomerase I and a specific binding sequence. , 1989, The Journal of biological chemistry.

[31]  R. Sternglanz,et al.  Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. , 1988, Molecular pharmacology.

[32]  W. Earnshaw,et al.  cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. G. Kelly,et al.  Purification and characterization of a type I DNA topoisomerase from calf thymus mitochondria. , 1987, Biochemistry.

[34]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[35]  G. Riou,et al.  Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. , 1986, Biochemistry.

[36]  O. Westergaard,et al.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in tetrahymena R-chromatin , 1985, Cell.

[37]  L. Liu,et al.  Association of eukaryotic DNA topoisomerase I with nucleosomes and chromosomal proteins. , 1983, Nucleic acids research.

[38]  W. Holloman,et al.  Purification and properties of a topoisomerase from Ustilago maydis. , 1981, The Journal of biological chemistry.

[39]  J. Champoux,et al.  The effect of salt on the binding of the eucaryotic DNA nicking-closing enzyme to DNA and chromatin. , 1981, Biochimica et biophysica acta.

[40]  L. Liu,et al.  Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Tocchini-Valentini,et al.  Purification and characterization of Xenopus laevis type I topoisomerase. , 1981, The Journal of biological chemistry.

[42]  J. Champoux Mechanism of the reaction catalyzed by the DNA untwisting enzyme: attachment of the enzyme to 3'-terminus of the nicked DNA. , 1978, Journal of molecular biology.

[43]  A. Riggs,et al.  Lac repressor-operator interaction. I. Equilibrium studies. , 1970, Journal of molecular biology.